Infection/DiseaseVaccineReplicatingPrimary courseIndicationNotes

Hepatitis B

Subunit

no

4 doses

All non-immune

Engerix B/HBvaxPRO 40μg; Fendrix 20μg 

Influenza

Inactivatedno

1 dose

All yearly

Quadrivalent vaccine preferred

Pneumococcus

Conjugated

no

1 dose

All once

PCV-13

Human papilloma virus 

VLP

no

3 doses

Age and gender related

4vHPV or 9vHPV preferred

Hepatitis A 

Inactivated

no

2-3 doses

At risk

3 doses if CD4 counts <350 cells/μL

Meningococcus 

Conjugated

no

2 doses

Age related, at risk

MenC, MenACWY

Meningococcus

Recombinant protein + OMV

no

2 doses

Age related, at risk

MenB

Pertussis

Acellular multicomponentno

1 dose

Pregnant women

Given as combined dTaP/IPV vaccine

Pneumococcus

Polysaccharide

no

1 dose

At risk, once

PPV-23

Measles, Mumps, Rubella

Live attenuated 

yes

2 doses

All non-immune

Given as combined MMR vaccine, CD4 >200 cells/μL

Varicella (chickenpox) 

Live attenuated

yes

2 doses

All non-immune

CD4 >200 cells/μL

Herpes zoster (shingles)

Live attenuated

yes

1 dose

All VZV IgG+, age related

CD4 >200 cells/μL